Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

JOURNAL ARTICLE published April 2013 in European Urology

Authors: Guru Sonpavde | Gregory R. Pond | Ronan Fougeray | Toni K. Choueiri | Angela Q. Qu | David J. Vaughn | Guenter Niegisch | Peter Albers | Nicholas D. James | Yu-Ning Wong | Yoo-Joung Ko | Srikala S. Sridhar | Matthew D. Galsky | Daniel P. Petrylak | Ulka N. Vaishampayan | Awais Khan | Nicholas J. Vogelzang | Tomasz M. Beer | Walter M. Stadler | Peter H. O'Donnell | Cora N. Sternberg | Jonathan E. Rosenberg | Joaquim Bellmunt